Bulletin
Investor Alert

Momenta Pharmaceuticals Inc.

NAS: MNTA

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Sep 25, 2020, 5:20 p.m.

/zigman2/quotes/200094979/composite

$

52.36

Change

-0.04 -0.08%

Volume

Volume 95,795

Quotes are delayed by 20 min

/zigman2/quotes/200094979/composite

Previous close

$ 52.39

$ 52.40

Change

+0.01 +0.02%

Day low

Day high

$52.36

$52.42

Open

52 week low

52 week high

$12.21

$52.45

Open

Georges Gemayel

Georges Gemayel is an American businessperson who has been at the helm of 10 different companies. He is Non-Executive Chairman of Enterome SA, Chairman for Orphazyme A, Chairman for Dynacure SAS and Chairman of OxThera AB. Dr. Gemayel is also on the board of Momenta Pharmaceuticals, Inc., Supernus Pharmaceuticals, Inc., International Institute of New England and Gemayel Family Foundation and Partner at Gemayel Investment LLC.

In the past Dr. Gemayel held the position of Executive Chairman of Vascular Magnetics, Inc., Chairman, President & Chief Executive Officer at Altus Pharmaceuticals, Inc., Chairman for Syndexa Pharmaceuticals Corp., Executive Chairman of Syndex Corp., Vice President-Specialty Care at Roche Corp., Executive Chairman for FoldRx Pharmaceuticals, Inc., Chairman for EpiTherapeutics ApS, Vice President-National Specialty Care at Hoffmann-La Roche, Inc., General Manager of Hoffmann-La Roche Portugal, General Manager of Roche Farmaceutica Quimica Ltda and Executive Vice President-Therapeutics at Genzyme Corp.

Dr. Gemayel received a doctorate from St. Joseph University and a doctorate and a graduate degree from Université Paris-Sud 11.

Transactions

Date Shares Transaction Value
08/05/2020 10,000   Disposition at $33 per share. 330,000
08/05/2020 10,000   Derivative/Non-derivative trans. at $14.84 per share. 148,400
07/29/2020 10,000   Disposition at $30 per share. 300,000
07/29/2020 10,000   Derivative/Non-derivative trans. at $14.84 per share. 148,400
06/20/2019 4,356   Derivative/Non-derivative trans. at $0 per share. 0
06/20/2018 5,734   Derivative/Non-derivative trans. at $0 per share. 0

Officers and Executives

Mr. Bruce L. Downey
Chairman
Mr. Craig A. Wheeler
President, Chief Executive Officer & Director
Dr. Young T. Kwon
Chief Financial & Business Officer
Dr. Santiago Arroyo
Chief Medical Officer & Senior VP-Development
Dr. Anthony M. Manning
Chief Scientific Officer
Mr. Ian D. Fier
Chief Manufacturing & Program Officer
Dr. Jane F. Barlow
Director
Ms. Agnieszka Cieplinska
Chief Accounting Officer
Ms. Patty Eisenhaur
Investor Relations Contact
Ms. Jo-Ann Beltramello
Chief Human Resources & Infrastructure Officer
Ms. Alejandra Veronica Carvajal
Secretary, Chief Legal Officer & General Counsel
Dr. Donna Roy Grogan
Independent Director
Dr. Elizabeth Stoner
Independent Director
Dr. Georges Gemayel
Independent Director
Dr. Jose Carlos Gutiérrez Ramos
Independent Director
Dr. Steven C. Gilman
Independent Director
Link to MarketWatch's Slice.